Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma.

Lu LJ, Tsai JC, Liu J.

Yale J Biol Med. 2017 Mar 29;90(1):111-118. eCollection 2017 Mar. Review.

2.

Cytokine biomarkers in tear film for primary open-angle glaucoma.

Gupta D, Wen JC, Huebner JL, Stinnett S, Kraus VB, Tseng HC, Walsh M.

Clin Ophthalmol. 2017 Feb 22;11:411-416. doi: 10.2147/OPTH.S125364. eCollection 2017.

3.

Characterizing the "POAGome": A bioinformatics-driven approach to primary open-angle glaucoma.

Danford ID, Verkuil LD, Choi DJ, Collins DW, Gudiseva HV, Uyhazi KE, Lau MK, Kanu LN, Grant GR, Chavali VRM, O'Brien JM.

Prog Retin Eye Res. 2017 May;58:89-114. doi: 10.1016/j.preteyeres.2017.02.001. Epub 2017 Feb 20. Review.

PMID:
28223208
4.

Neuroprotection for treatment of glaucoma in adults.

Sena DF, Lindsley K.

Cochrane Database Syst Rev. 2017 Jan 25;1:CD006539. doi: 10.1002/14651858.CD006539.pub4. Review.

PMID:
28122126
5.

Ocular Response Analyzer.

Kaushik S, Pandav SS.

J Curr Glaucoma Pract. 2012 Jan-Apr;6(1):17-19. Epub 2012 Oct 16.

6.

Comparison of Bruch's Membrane Opening Minimum Rim Width Among Those With Normal Ocular Health by Race.

Rhodes LA, Huisingh CE, Quinn AE, McGwin G Jr, LaRussa F, Box D, Owsley C, Girkin CA.

Am J Ophthalmol. 2017 Feb;174:113-118. doi: 10.1016/j.ajo.2016.10.022. Epub 2016 Nov 5.

PMID:
27825982
7.

Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.

De Moraes CG, Liebmann JM, Levin LA.

Prog Retin Eye Res. 2017 Jan;56:107-147. doi: 10.1016/j.preteyeres.2016.10.001. Epub 2016 Oct 20. Review.

PMID:
27773767
8.

Trends in Prevalence of Diagnosed Ocular Disease and Utilization of Eye Care Services in American Veterans.

Saeedi O, Ashraf H, Slade EP, Medoff DR, Li L, Friedman DS, Kreyenbuhl J.

Am J Ophthalmol. 2017 Jan;173:70-75. doi: 10.1016/j.ajo.2016.09.030. Epub 2016 Oct 1.

PMID:
27702620
9.

A randomized, controlled trial to test the effectiveness of a glaucoma patient navigator to improve appointment adherence.

Hark LA, Johnson DM, Berardi G, Patel NS, Zeng L, Dai Y, Mayro EL, Waisbourd M, Katz LJ.

Patient Prefer Adherence. 2016 Sep 8;10:1739-48. doi: 10.2147/PPA.S108391. eCollection 2016.

10.

Reductions in Retrobulbar and Retinal Capillary Blood Flow Strongly Correlate With Changes in Optic Nerve Head and Retinal Morphology Over 4 Years in Open-angle Glaucoma Patients of African Descent Compared With Patients of European Descent.

Siesky B, Harris A, Carr J, Verticchio Vercellin A, Hussain RM, Parekh Hembree P, Wentz S, Isaacs M, Eckert G, Moore NA.

J Glaucoma. 2016 Sep;25(9):750-7. doi: 10.1097/IJG.0000000000000520.

PMID:
27561102
11.

Retinal Structures and Visual Cortex Activity are Impaired Prior to Clinical Vision Loss in Glaucoma.

Murphy MC, Conner IP, Teng CY, Lawrence JD, Safiullah Z, Wang B, Bilonick RA, Kim SG, Wollstein G, Schuman JS, Chan KC.

Sci Rep. 2016 Aug 11;6:31464. doi: 10.1038/srep31464.

12.

Comparison of Peristat Online Perimetry with the Humphrey Perimetry in a Clinic-Based Setting.

Lowry EA, Hou J, Hennein L, Chang RT, Lin S, Keenan J, Wang SK, Ianchulev S, Pasquale LR, Han Y.

Transl Vis Sci Technol. 2016 Jul 19;5(4):4. eCollection 2016 Jul.

13.

Eye Care Quality and Accessibility Improvement in the Community (EQUALITY): impact of an eye health education program on patient knowledge about glaucoma and attitudes about eye care.

Rhodes LA, Huisingh CE, McGwin G Jr, Mennemeyer ST, Bregantini M, Patel N, Saaddine J, Crews JE, Girkin CA, Owsley C.

Patient Relat Outcome Meas. 2016 May 19;7:37-48. doi: 10.2147/PROM.S98686. eCollection 2016.

14.

The Philadelphia Glaucoma Detection and Treatment Project: Detection Rates and Initial Management.

Waisbourd M, Pruzan NL, Johnson D, Ugorets A, Crews JE, Saaddine JB, Henderer JD, Hark LA, Katz LJ.

Ophthalmology. 2016 Aug;123(8):1667-74. doi: 10.1016/j.ophtha.2016.04.031. Epub 2016 May 22.

PMID:
27221736
15.

Human TBK1: A Gatekeeper of Neuroinflammation.

Ahmad L, Zhang SY, Casanova JL, Sancho-Shimizu V.

Trends Mol Med. 2016 Jun;22(6):511-27. doi: 10.1016/j.molmed.2016.04.006. Review.

16.

Visual Impairment and Blindness in Adults in the United States: Demographic and Geographic Variations From 2015 to 2050.

Varma R, Vajaranant TS, Burkemper B, Wu S, Torres M, Hsu C, Choudhury F, McKean-Cowdin R.

JAMA Ophthalmol. 2016 Jul 1;134(7):802-9. doi: 10.1001/jamaophthalmol.2016.1284.

17.

Prevalence of Glaucoma in the United States: The 2005-2008 National Health and Nutrition Examination Survey.

Gupta P, Zhao D, Guallar E, Ko F, Boland MV, Friedman DS.

Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2577-85. doi: 10.1167/iovs.15-18469.

18.

User-centered Design of the eyeGuide: A Tailored Glaucoma Behavior Change Program.

Killeen OJ, MacKenzie C, Heisler M, Resnicow K, Lee PP, Newman-Casey PA.

J Glaucoma. 2016 Oct;25(10):815-821.

PMID:
27096721
19.

Evaluating glaucoma damage: emerging imaging technologies.

Kostanyan T, Wollstein G, Schuman JS.

Expert Rev Ophthalmol. 2015;10(2):183-195. Epub 2015 Feb 9.

20.

Evaluation of the associations between changes in intraocular pressure and metabolic syndrome parameters: a retrospective cohort study in Japan.

Yokomichi H, Kashiwagi K, Kitamura K, Yoda Y, Tsuji M, Mochizuki M, Sato M, Shinohara R, Mizorogi S, Suzuki K, Yamagata Z.

BMJ Open. 2016 Mar 24;6(3):e010360. doi: 10.1136/bmjopen-2015-010360.

Supplemental Content

Support Center